NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults3 Aug 2026
Kajaria Ceramics Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Kajaria Ceramics Limited's Q1 FY27 earnings conference call transcript has been uploaded, showcasing a 20% consolidated revenue growth and 6% year-to-year volume growth, despite geopolitical disruptions. The company remains optimistic about its business outlook for FY27, with a strong foundation for the year ahead.
BSECompany Update▲ PositiveResults3 Aug 2026
Kajaria Ceramics Ltd
In continuation of our letter dated July 31, 2026, informing about the uploading of the audio recording of the Conference Call held on July 31, 2026, we enclose herewith transcript of the ....
Kajaria Ceramics Ltd's Q1 FY27 earnings conference call highlights a 6% year-to-year volume growth, 20% revenue growth, and 19.60% EBITDA margin. The company is optimistic about its business outlook for FY27, despite recent geopolitical disruptions. New initiatives include a brownfield expansion, a further 11 million square meters line at the Gailpur facility, and the acquisition of the remaining 15% stake in Kerovit.
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults3 Aug 2026
Privi Speciality Chemicals Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Privi Speciality Chemicals Limited has informed the Exchange about Transcript of Earning Call held on Friday 31 July 2026. The company reported revenue of Rs. 666 crore, reflecting growth of 19.22% year-on-year, supported by healthy demand across both domestic and international markets.
NSEPress Release▲ PositiveResults3 Aug 2026
GPT Healthcare Limited
Press Release
GPT Healthcare Limited reported its unaudited financial results for Q1FY27, with a total income of Rs 128 crore, a growth of 18% y-o-y. The company maintained a competitive and affordable ARPOB at INR42,350 while recording steady improvement in occupancy rates at 58.07%. Key operational highlights include the completion of over 700+ renal transplants at ILS Dum Dum, the launch of Robotic Knee Surgery programme at ILS Howrah, and the delivery of over 700 radiation therapy procedures at ILS Agartala.
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults3 Aug 2026
Strides Pharma Science Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Strides Pharma Science Limited has announced its unaudited financial results for the quarter ended June 30, 2026, with a 13% year-on-year growth in topline, driven by broad-based contributions across its business, and maintained EBITDA margins at 18.2% despite external pressures.
NSEPress Release▲ PositiveResults3 Aug 2026
Torrent Power Limited
Press Release
Torrent Power Limited announces Q1 FY27 results, with revenue from operations at ₹8,124 Crs, EBITDA at ₹1,619 Crs, and Total Comprehensive Income (TCI) at ₹639 Crs. The company delivered EBITDA growth of 2% despite a challenging operating environment. Key factors influencing performance were improved operational performance across distribution businesses, improved performance of renewable portfolio, and higher finance costs.
BSECompany Update▲ PositiveResults3 Aug 2026
DLF Ltd
DLF Announces Financial Results for Q1FY27
DLF Ltd has announced its Q1FY27 financial results, with net profit at Rs 794 crore, a 4% y-o-y growth. The company has also reported operating cash flow of Rs 1,317 crore and a net cash position of Rs 15,200 crore. The company's rental portfolio continues to demonstrate robust operating strength with industry-leading occupancy of 95%.
BSECompany Update▲ PositiveResults3 Aug 2026
Privi Speciality Chemicals Ltd
Transcript of Earning Call held on Friday July 31, 2026.
Privi Speciality Chemicals Ltd has announced its Q1 FY27 earnings, with revenue of Rs. 666 crore, a 19.22% year-on-year growth. The company reported healthy demand across both domestic and international markets, despite adverse global headwinds. The management emphasized the importance of executing the expansion projects, strengthening the specialty product portfolio, and building on long-standing customer relationships.
NSEPress Release▲ PositiveResults3 Aug 2026
DLF Limited
Press Release
DLF Limited announces financial results for Q1FY27, with net profit at Rs 794 crore, y-o-y growth of 4%, operating cash flow of Rs 1,317 crore, and new sales bookings for the quarter stood at Rs 657 crore.
BSECompany Update▲ PositiveResults3 Aug 2026
Fabtech Technologies Ltd
Transcript of Earnings Call - July 2026
Fabtech Technologies Ltd reported a 10% year-on-year revenue growth and a full turnaround from a loss to a profit in Q1 FY27, despite a challenging global environment. The company's consolidated revenue stood at Rupees 74.98 crore, with a net profit of Rupees 4.21 crores and an EBITDA margin of 9%. The management attributed the turnaround to its geographical mix shifting towards higher value markets and a stellar performance from its Saudi operations.
BSECompany Update▲ PositiveResults3 Aug 2026
GPT Healthcare Ltd
Please find enclosed press release on UFR for Q1FY2027
GPT Healthcare Limited reported unaudited financial results for Q1FY27, with total income at Rs 128 crore, a growth of 18% y-o-y. EBITDA and PAT stood at Rs 26.2 crore and Rs 12.7 crore, respectively. The company maintained a competitive ARPOB and recorded steady improvement in occupancy rates. Key operational highlights included the completion of over 700+ renal transplants, launch of robotic knee surgery programme, and delivery of over 700 radiation therapy procedures.
BSECompany Update▲ PositiveResults3 Aug 2026
Strides Pharma Science Ltd
Transcript of Earnings Call pertaining to Unaudited Financial Results of the Company for the quarter ended June 30, 2026.
Strides Pharma Science Ltd reported Q1 FY27 results, with 13% YoY growth in topline, driven by broad-based contributions across its business, and maintained EBITDA margins at 18.2% despite additional operating and freight costs.
NSEPress Release▲ PositiveResults3 Aug 2026
Noida Toll Bridge Company Limited
Press Release
Noida Toll Bridge Company Limited has announced its Q1FY27 financial results, with revenue increasing by 15.51% to ₹ 12.81 crore and profit after tax (PAT) rising by 28.73% to ₹ 5.33 crore. The company has completed the second phase of carriageway upgradation and initiated a 5-year preventive maintenance programme.
NSEInvestor Presentation▲ PositiveResults3 Aug 2026
GPT Healthcare Limited
Investor Presentation
GPT Healthcare Limited has submitted an investor presentation on its un-audited financial results for the 1st quarter ended June 30, 2026, highlighting a healthy operational performance with an increase in average revenue per occupied bed (ARPOB) driven by an improved clinical mix and operating efficiencies.
BSECompany Update▲ PositiveResults3 Aug 2026
GPT Healthcare Ltd
Please find Investor Presentation on UFR for Q1FY2027.
GPT Healthcare Ltd has submitted an investor presentation on its un-audited financial results for Q1FY2027, showing healthy operational performance with an increase in average revenue per occupied bed (ARPOB) to ₹42350 driven by improved clinical mix and operating efficiencies.
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults3 Aug 2026
Fabtech Technologies Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Fabtech Technologies Limited has reported a 10% year-on-year growth in consolidated revenue for Q1 FY27, with a net profit of Rs. 4.21 crores against a net loss of Rs. 6.13 crores in the corresponding quarter last year. The company's EBITDA came in at Rs. 7.41 crores with a margin of 9%, a decisive recovery from a negative EBITDA of Rs. 5.27 crores in Q1 FY26.
BSECompany Update▲ PositiveResults3 Aug 2026
Noida Toll Bridge Company Ltd
Please refer media release pertaining with Financial Results for the quarter ended June 30, 2026.
Noida Toll Bridge Company Ltd announced Q1FY27 financial results, with revenue increasing 15.51% to ₹ 12.81 crore and profit after tax (PAT) rising 28.92% to ₹ 5.33 crore. The company completed the second phase of carriageway upgradation and initiated a 5-year preventive maintenance program.
NSEPress Release▲ PositiveResults3 Aug 2026
Avadh Sugar & Energy Limited
Press Release
Avadh Sugar & Energy Limited has announced its quarterly earnings release for Q1 FY27, with total income at Rs. 781.05 Cr, EBITDA at Rs. 38.25 Cr, and PAT at Rs. 0.24 Cr.
BSECompany Update▲ PositiveResults3 Aug 2026
Avadh Sugar & Energy Ltd
Press Release in respect of the Unaudited Financial Results of the Company for the quarter ended 30th June 2026
Avadh Sugar & Energy Ltd has announced its unaudited financial results for Q1 FY27, showing a 9% increase in total income to Rs. 781.05 Cr, and a significant improvement in EBITDA to Rs. 38.25 Cr and PAT to Rs. 0.24 Cr. The company's distillery and ethanol operations delivered strong growth, and the management remains committed to sustainable and inclusive growth.
BSEResult▲ PositiveResults3 Aug 2026
Veljan Denison Ltd
Veljan Denison Limited- Unaudited Financials Results( Standalone and Consolidated) for the Quarter ended 30.06.2026 along with Limited Review Report issued by Statutory Auditors of the ....
Veljan Denison Ltd has announced its unaudited financial results for the quarter ended 30.06.2026, showing a profit of Rs. 746.19 lakhs and a revenue from operations of Rs. 4,013.60 lakhs. The company's business activity falls within a single business segment - Hydraulic Products. The results have been reviewed by the audit committee and approved by the board.